Enzymatic treatment transforms trypomastigotes of Trypanosoma cruzi into activators of alternative complement pathway and potentiates their uptake by macrophages
about
Evasion and Immuno-Endocrine Regulation in Parasite Infection: Two Sides of the Same Coin in Chagas Disease?Role of Trypanosoma cruzi Trans-sialidase on the Escape from Host Immune SurveillanceImmune Evasion Strategies of Trypanosoma cruziPathogenesis of chagas' disease: parasite persistence and autoimmunityA partial cDNA clone of trypomastigote decay-accelerating factor (T-DAF), a developmentally regulated complement inhibitor of Trypanosoma cruzi, has genetic and functional similarities to the human complement inhibitor DAF.A Brief View of the Surface Membrane Proteins from Trypanosoma cruzi.Inhibitory effects of Trypanosoma cruzi sialoglycoproteins on CD4+ T cells are associated with increased susceptibility to infectionIdentification of the gene family encoding the 160-kilodalton Trypanosoma cruzi complement regulatory proteinDesialylation of lysosomal membrane glycoproteins by Trypanosoma cruzi: a role for the surface neuraminidase in facilitating parasite entry into the host cell cytoplasm.Receptor for immunoglobulin Fc on pathogenic but not on nonpathogenic protozoa of the Trypanosomatidae.gp72, the 72 kilodalton glycoprotein, is the membrane acceptor site for C3 on Trypanosoma cruzi epimastigotes.Amastigotes of Trypanosoma cruzi escape destruction by the terminal complement components.Enhanced resistance to acute infection with Trypanosoma cruzi in mice treated with an interferon inducerSusceptibility of pathogenic and nonpathogenic Naegleria spp. to complement-mediated lysis.Challenge of chronically infected mice with homologous trypanosoma cruzi parasites enhances the immune response but does not modify cardiopathy: implications for the design of a therapeutic vaccine.Recent developments in the field of Chagas' disease.Resistance of highly pathogenic Naegleria fowleri amoebae to complement-mediated lysis.Externally disposed membrane polypeptides of intact and protease-treated Trypanosoma lewisi correlated with sensitivity to alternate complement pathway-mediated lysisEvasion of alternative complement pathway by Trypanosoma cruzi results from inefficient binding of factor B.The Role of Sialic Acid-Binding Receptors (Siglecs) in the Immunomodulatory Effects of Trypanosoma cruzi Sialoglycoproteins on the Protective Immunity of the Host.Stage-specific expression and intracellular shedding of the cell surface trans-sialidase of Trypanosoma cruzi.Trypanolytic activity, agglutinins, and opsonins in sera from animals refractory to Trypanosoma lewisi.Developmentally-regulated virulence factors of Trypanosoma cruzi and their relationship to evasion of host defences.Trypanosoma cruzi Evades the Complement System as an Efficient Strategy to Survive in the Mammalian Host: The Specific Roles of Host/Parasite Molecules and Trypanosoma cruzi Calreticulin.Comparison of the C-mediating killing activity and C-activating properties of mouse monoclonal and polyclonal antibodies against Trypanosoma cruzi.Infectivity of amastigotes of Trypanosoma cruzi.Changes in cell surface anionogenic groups during differentiation of Herpetomonas samuelpessoai mediated by dimethylsulfoxide.Progrès récents dans le domaine de la maladie de Chagas.Complement resistance of human carcinoma cells depends on membrane regulatory proteins, protein kinases and sialic acid.Antibody-dependent cell cytotoxicity against Trypanosoma cruzi is only mediated by protective antibodies.
P2860
Q26744672-EAC147C2-1502-4729-9ECF-A1282897AB6BQ26752320-87497BF1-0030-4207-A6A5-520F88453B83Q26799180-438CDC19-713D-4FB9-9D74-67E48C7DF8CBQ28742827-4B4E8D5E-63EB-41D5-BD6D-7723E694CA27Q33607295-96BC1794-8A5A-44CE-AE9F-AE0B58F23DDCQ33809852-42494A7A-5144-48FF-A116-F2B99B38E7C4Q35035389-DE128224-52C5-4116-86A6-0585A0A8E61CQ35534415-E6D2C2EF-1A6A-42F5-9651-63D30CEC9025Q36231609-18851C38-C7E4-4ADC-ABDB-7AA4D1BD9852Q36345962-70050B1B-AC1B-4BDE-83B6-74F427C9BAF8Q36350028-4F9857E1-1DCD-42E4-82C4-8B1260057367Q36356128-D497E685-A218-4E77-B613-DCD4E52B1E37Q36436042-5CBD8214-1EC1-4DD4-9957-42275CE52336Q36471227-63CBC849-BDC7-4F6C-BCFB-D5A1A32FF3BDQ36606779-1428E16A-5531-4F0D-8A7E-E45DF09653ECQ36874797-0C6E3368-C2F5-4389-AB9E-E7D5337A95C4Q37007198-166DA7BB-48BB-436C-8BE2-27B1643F154BQ37099860-F874ECED-C690-4720-8549-DC3AF6EC2982Q37397900-82F3B784-B4D7-4A85-A360-68B361A93B29Q38181143-9C33BD23-83B4-4DF5-B7DC-FB2DFA68A1C3Q40146889-355D9755-AA28-4F64-A15A-641704264D73Q40170657-F8AF1CEB-216F-4CA5-A967-E9C7FB1BF047Q40891261-209E0D19-AF53-491B-85E6-2B11D7DBFD49Q41619655-AA30853C-8E7A-4A03-9EDE-852DA1360035Q41819279-F9DA3C6E-CF8B-4214-98AF-607D0F24AB6DQ43508082-72237BBF-1670-4E97-B8F7-4364D7F4931EQ45084501-D4D74176-E40B-4184-9AAA-5615EBB83750Q46163762-31C0C431-903E-4A2C-9901-B1154584E7DBQ53942590-ED6AC48D-7390-41AD-A1CB-698C986439D7Q54447650-ABBCC658-38FE-4EB8-AD84-24E8090C458A
P2860
Enzymatic treatment transforms trypomastigotes of Trypanosoma cruzi into activators of alternative complement pathway and potentiates their uptake by macrophages
description
1981 nî lūn-bûn
@nan
1981 թուականի Յունուարին հրատարակուած գիտական յօդուած
@hyw
1981 թվականի հունվարին հրատարակված գիտական հոդված
@hy
1981年の論文
@ja
1981年論文
@yue
1981年論文
@zh-hant
1981年論文
@zh-hk
1981年論文
@zh-mo
1981年論文
@zh-tw
1981年论文
@wuu
name
Enzymatic treatment transforms ...... es their uptake by macrophages
@ast
Enzymatic treatment transforms ...... es their uptake by macrophages
@en
type
label
Enzymatic treatment transforms ...... es their uptake by macrophages
@ast
Enzymatic treatment transforms ...... es their uptake by macrophages
@en
prefLabel
Enzymatic treatment transforms ...... es their uptake by macrophages
@ast
Enzymatic treatment transforms ...... es their uptake by macrophages
@en
P2093
P2860
P356
P1476
Enzymatic treatment transforms ...... es their uptake by macrophages
@en
P2093
P2860
P304
P356
10.1073/PNAS.78.1.602
P407
P577
1981-01-01T00:00:00Z